SEC Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 18, 2016
Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or other jurisdiction of Incorporation)
|
| | |
| | |
001-12215 | | 16-1387862 |
(Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
Three Giralda Farms Madison, NJ 07940 | | 07940 |
(Address of principal executive offices) | | (Zip Code) |
| | |
(973) 520-2700 |
(Registrant’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
| |
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure
On May 18, 2016 Quest Diagnostics Incorporated issued a press release (the "Press Release") announcing, among other things, (i) that it completed the recently announced sale of its Focus Diagnostics products business and (ii) an updated outlook for full year 2016. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 8.01. Other Events
The Press Release also announces that Quest Diagnostics plans to use the proceeds of the sale of the Focus Diagnostics products business to repurchase its common stock, which is consistent with its strategy to deliver disciplined capital deployment and will bring the amount of capital stock repurchased since 2012 to approximately $2 billion.
Item 9.01. Financial Statements and Exhibits
|
| | |
d. | Exhibit | Description |
| | |
| 99.1 | Press release of Quest Diagnostics Incorporated dated May 18, 2016.
|
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
May 18, 2016
|
| |
QUEST DIAGNOSTICS INCORPORATED |
| |
By: | /s/ William J. O'Shaughnessy, Jr. |
| William J. O'Shaughnessy, Jr. |
| Deputy General Counsel and |
| Corporate Secretary |